Evidence map›Paper›PMID 29362998›Full record

ArticleSurgical case reports2018

Cancer-associated retinopathy after surgery for breast cancer: a case report and review of the literature.

Mirei Kamei, Yutaka Fujitomi, Yoshiyuki Kondo, Toru Adachi, Kohei Shibata, Yohei Takumi, Miyuki Abe, Kenji Sugio

Open access · goldAbstract read
In one paragraph

Article in Surgical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mirei KameiDepartment of Surgery, Tsurumi Hospital, 4333 Tsurumi, Beppu, Oita, 874-8585, Japan. mirei65@oita-u.ac.jp.
Yutaka FujitomiDepartment of Surgery, Tsurumi Hospital, 4333 Tsurumi, Beppu, Oita, 874-8585, Japan.
Yoshiyuki KondoDepartment of Pathology, Tsurumi Hospital, 4333 Tsurumi, Beppu, Oita, 874-8585, Japan.
Toru AdachiDepartment of Ophthalmology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5503, Japan.
Kohei ShibataDepartment of Surgery, Tsurumi Hospital, 4333 Tsurumi, Beppu, Oita, 874-8585, Japan.
Yohei TakumiDepartment of Thoracic and Breast Surgery, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5503, Japan.
Miyuki AbeDepartment of Surgery, Tsurumi Hospital, 4333 Tsurumi, Beppu, Oita, 874-8585, Japan.
Kenji SugioDepartment of Thoracic and Breast Surgery, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5503, Japan.
Tsurumi University · JPOita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 50-year-old Japanese woman with breast cancer who complained of blurred vision and central scotoma in her left eye on the 12th day after surgery. Subsequently, the sudden-onset binocular visual disorder progressed, and she was diagnosed with cancer-associated retinopathy (CAR) based on the clinical findings. Although her visual acuity temporarily improved following the start of adjuvant chemotherapy, reductions in her visual acuity progressed once again. After two courses of steroid pulse therapy initiated from the 59th day following the onset of CAR, although her visual field was still constricted, her binocular visual acuity improved from finger movement to 0.8 2 months later. The shorter the period from onset to treatment, the better the prognosis of the visual function. However, a diagnosis is often delayed because the incidence of this disease is very rare. Therefore, it is important to suspect CAR whenever a sudden visual disorder develops in cancer patients. Furthermore, treatment is believed to be effective even if steroid therapy is started up to 2 months from onset.

Indexed as

Cancer-associated retinopathyInvasive carcinoma with neuroendocrine featuresSteroid pulse therapy

Identifiers

PMID29362998
PMCPMC5780336
OpenAlexW2789868989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.